Showing 1521-1530 of 19297 results for "".
Unpacking Post-COVID Cognitive Changes: The Potential Role of Immune Exhaustion
https://reachmd.com/programs/clinicians-roundtable/unpacking-post-covid-cognitive-changes-the-potential-role-of-immune-exhaustion/35466/A recent prospective study evaluated long-term cognitive outcomes in post-COVID patients using advanced imaging, biomarker analysis, and specialist assessments. It revealed a pattern suggestive of immune exhaustion, including elevated markers tied to wound healing and blood-brain barrier integrity aImproving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
https://reachmd.com/programs/neurofrontiers/improving-diagnostic-accuracy-in-ms-criteria-challenges-and-innovations/32782/Accurately diagnosing multiple sclerosis (MS) involves understanding the diagnostic criteria, recognizing red flags to avoid misdiagnosis, and keeping up with new tools. Dr. Andrew Solomon, Professor and Interim Chair of the Department of Neurological Sciences and Chief of the Multiple Sclerosis DivLooking Beyond the Skin: The Far-Reaching Impacts of Psoriasis
https://reachmd.com/programs/frontlines-psoriasis/looking-beyond-the-skin-the-far-reaching-impacts-of-psoriasis/32436/Discover how the impacts of psoriasis extend beyond the skin, affecting quality of life, musculoskeletal health, and overall well-being.Climate Change in the Clinic: Examining Neurological Impacts
https://reachmd.com/programs/neurofrontiers/climate-change-in-the-clinic-examining-neurological-impacts/32783/The impacts of climate change present a growing threat to brain health. Rising heat, air pollution, and oxidative stress appear to worsen conditions like stroke, dementia, and multiple sclerosis. Join Dr. Beth Malow as she outlines the essential role clinicians play in prevention and education. Dr.Melanoma Treatment Breakthroughs: Improving Long-Term Survival
https://reachmd.com/programs/medical-industry-feature/melanoma-treatment-breakthroughs-improving-long-term-survival/32930/Explore how early immunotherapy and emerging treatments are reshaping survival rates for patients with melanoma.FcRn Inhibitors: A Potential New Targeted Therapy Option
https://reachmd.com/programs/neurofrontiers/tbd/30071/Here’s how FcRn inhibitors can offer a new approach to generalized myasthenia gravis treatment.Insights on the Rising Rates of Syphilis in the United States
https://reachmd.com/programs/clinicians-roundtable/insights-on-the-rising-rates-of-syphilis-in-the-united-states/24153/The United States has seen a 200% increase in congenital syphilis cases in the past five years. Here’s why.Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
https://reachmd.com/programs/medical-industry-feature/against-the-odds-improving-survival-for-children-with-pulmonary-vein-stenosis/18096/Tune in to learn about innovations that are improving pulmonary vein stenosis survival rates.Improving Outcomes of HIV Among the Latino Population
https://reachmd.com/programs/clinicians-roundtable/improving-outcomes-of-hiv-among-the-latino-population/15747/What strategies will help decrease the rates of HIV infections within the Latino community? Dive in.Bringing Injectable Treatment to HIV Patients in Atlanta
https://reachmd.com/programs/clinicians-roundtable/bringing-injectable-treatment-to-hiv-patients-in-atlanta/15829/From using tablets for PrEP to incorporating an injectable therapy for HIV patients, learn how the PrEP program is helping medication access in Atlanta, Georgia.